Yearly flu shot alternative? new drug tested for Long-Term safety
NCT ID NCT07225959
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests the safety of giving repeated annual doses of an experimental drug called CD388 to healthy adults. About 400 people who already tolerated one dose without serious side effects will receive two more doses over two years. Researchers will monitor for side effects and check if the body makes antibodies against the drug, which could affect how well it works.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Floridian Clinical Research
Miami Lakes, Florida, 33016, United States
-
Spartanburg Medical Research
Spartanburg, South Carolina, 29303, United States
-
hVIVO Serviced Limited
London, England, E1 1EQ, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a common antifungal change how an experimental drug acts?
- Can a new injection help tackle obesity? a safety trial begins
- Will a new pill formula absorb the same? a trial puts it to the test
- Can a new drug tame Alzheimer's? early trial aims to find out
- Could sitting too much alter your nervous system?
- Could a cancer drug alter Metformin's effects? a trial investigates